Trials / Completed
CompletedNCT04219592
IgG-4 Levels in Systemic Sclerosis
Comparing IgG-4 Levels in Systemic Sclerosis Patients vs. Healthy Controls
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 154 (actual)
- Sponsor
- Meir Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This is an observational - non interventional study. The investigators will compare IgG4 levels of 80 healthy donors (from Israel blood bank - MDA) and 80 Systemic Sclerosis patients from Meir Medical Center.
Detailed description
IgG4 levels will be obtained from medical records of 80 SSc patients between the years 2000-2019. These will be compared to IgG4 levels from sera of 80 healthy donors (from Israel blood-bank - MDA). Correlations between IgG4 levels and the following will be made: age, sex, disease type (limited or diffused SSc), disease duration, medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | IgG4 measurement (non-interventional, just obtaining data from medical records) | IgG4 measurement in mg/dL |
Timeline
- Start date
- 2019-05-30
- Primary completion
- 2024-09-30
- Completion
- 2024-10-30
- First posted
- 2020-01-07
- Last updated
- 2025-05-16
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04219592. Inclusion in this directory is not an endorsement.